Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME CAPABILITIES Why Single Cell SNV SNV + CNV DNA + Protein Applications Oncology Research Precision Medicine Genome Editing Biomarker Development Cell and Gene Therapy Products & Services Tapestri Platform Panels Pharma Assay Development
RESOURCES BLOG PODCAST COMPANY About Us Careers Newsroom Events Distributors & Service Providers SUPPORT CENTER CONTACT PORTAL
X
Home Events ASH Annual Meeting & Expo 2022
Events

ASH Annual Meeting & Expo 2022

Hybrid
New Orleans, Louisiana
December 10 - December 13, 2022

Ernest N. Morial Convention Center
900 Convention Center Blvd
New Orleans, LA 70130

Booth #2014

Directions
Register

Our Chief Medical Officer, Todd Druley, Business Development, and Translational Applications Liaison teams will be at the 64th ASH Annual Meeting and Exposition on December 10-13, 2022 at the Ernest N. Morial Convention Center in New Orleans, Louisiana (Booth #2014). If you are attending and would like to learn more about our single-cell MRD assay or how to enable single-cell multi-omics, please click the “Register” link above and fill out the form. We will be in contact shortly.

SESSION
Integrative Analysis of Blast Phase Chronic Myelomonocytic Leukemia Reveals Distinct Transformation Phenotypes Predictive of Drug Response
DATE & TIME
12.10.2022
10:00AM CST
LOCATION
260-262
PUBLICATION
NUMBER
87
PRESENTERS
K. Gurashi, University of Manchester
SESSION
Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Genomic Lesions and Therapeutic Implications
DATE & TIME
12.10.2022
2:00PM CST
LOCATION
291-292
PUBLICATION
NUMBER
223
PRESENTERS
H. Döhner, MD, Servier Pharmaceuticals
SESSION
Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis
DATE & TIME
12.10.2022
4:30PM CST
LOCATION
275-277
PUBLICATION
NUMBER
327
PRESENTERS
Bridget K Marcellino, Icahn School of Medicine, Mount Sinai
SESSION
Identification of PTPN11 mutations As Early Events in the Development of Acute Myeloid Leukemia
DATE & TIME
12.10.2022
5:00PM CST
LOCATION
388-390
PUBLICATION
NUMBER
305
PRESENTERS
S. Fobare, Ohio State University Comprehensive Cancer Center
SESSION
Utilization of the Tapestri Platform for Quantification of Single Cell Vector Copy Number in CAR T Cell Products
DATE & TIME
12.10.2022
5:30PM CST
LOCATION
Hall D
PUBLICATION
NUMBER
2182
PRESENTERS
L. A. Murphy, University of Colorado
SESSION
Clonal Architecture and Evolution of Waldenström’s Macroglobulinemia at the Single Cell Level
DATE & TIME
12.10.2022
5:30PM CST
LOCATION
Hall D
PUBLICATION
NUMBER
1524
PRESENTERS
C. Jiménez, University Hospital of Salamanca
SESSION
Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric Acute Myeloid Leukemia Stem Cells
DATE & TIME
12.10.2022
5:30PM CST
LOCATION
Hall D
PUBLICATION
NUMBER
1452
PRESENTERS
I. Van Der Werf, Amsterdam University Medical Center
SESSION
Cirmtuzumab (Zilovertamab) Eliminates ROR1 Positive Leukemia Stem Cells By Blocking Niche Dependent ROR1/WNT5a Signaling
DATE & TIME
12.10.2022
5:30PM CST
LOCATION
Hall D
PUBLICATION
NUMBER
1453
PRESENTERS
L. Balaian, Moores Cancer Center and Sanford Stem Cell Clinical Center
SESSION
Molecular Characterization of Adult Acute Lymphoblastic Leukemia Identifies a Subgroup with Myeloid Mutations and Pre-Existing Clonal Hematopoiesis
DATE & TIME
12.11.2022
10:30AM CST
LOCATION
Great Hall AD
PUBLICATION
NUMBER
437
PRESENTERS
Caner Saygin, MD, University of Chicago
SESSION
Comprehensive Genomic Landscape and Clonal Architecture in Pediatric Patients with Monosomy 7
DATE & TIME
12.11.2022
6:00PM CST
LOCATION
Hall D
PUBLICATION
NUMBER
2589
PRESENTERS
T. Westover, St. Jude's Children's Research Hospital
SESSION
Multi-Omic Single-Cell Sequencing Reveals Genetic and Immunophenotypic Clonal Selection in Patients With FLT3-Mutated AML Treated With Gilteritinib/Venetoclax
DATE & TIME
12.12.2022
5:00PM CST
LOCATION
353-355
PUBLICATION
NUMBER
933
PRESENTERS
V.E. Kennedy, University of California San Francisco
SESSION
Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia
DATE & TIME
12.12.2022
5:30PM CST
LOCATION
Theater C
PUBLICATION
NUMBER
947
PRESENTERS
T. Robinson, Memorial Sloan Kettering Cancer Center
SESSION
Multiomic Single-Cell Sequencing of Mixed Phenotypic Acute Leukemia (MPAL) Reveals Complex Immunophenotypic, Transcriptional, and Genetic Heterogeneity
DATE & TIME
12.12.2022
6:00PM CST
LOCATION
Hall D
PUBLICATION
NUMBER
4120
PRESENTERS
V.E. Kennedy, University of California San Francisco
SESSION
Utilization of the Tapestri Platform for Quantification of Single Cell Vector Copy Number in CAR T Cell Products
DATE & TIME
12.10.2022
5:30PM CST
LOCATION
TBD
PUBLICATION
NUMBER
2182
PRESENTERS
L. Murphy, University of Colorado
SESSION
AML single-cell multi-omics MRD (scMRD) and the horizon of clinical utility
DATE & TIME
12.11.2022
4:00PM CST
LOCATION
Theater 6
PRESENTERS
Aaron Llanso, Mission Bio

SIGN UP FOR PRODUCT AND EVENT UPDATES
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CAPABILITIES
Why Single Cell SNV SNV + CNV DNA + Protein
APPLICATIONS
Oncology Research Precision Medicine Genome Editing Biomarker Development Cell and Gene Therapy
PRODUCTS & SERVICES
Tapestri Platform Panels Pharma Assay Development
COMPANY CAREERS NEWSROOM EVENTS BLOG RESOURCES SUPPORT CENTER CONTACT Terms of Use Privacy Policy Terms and Conditions of Sale Client Data Security & Retention
REQUEST QUOTE